3 European Stocks Estimated At Up To 41.3% Discount To Intrinsic Value

As European markets navigate the complexities of potential EU-U.S. trade deals and a slightly hawkish stance from the European Central Bank, investors are keenly observing opportunities that may arise from these developments. In this context, identifying stocks that are undervalued can be particularly appealing, as they offer potential value against a backdrop of cautious optimism in the market.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name Current Price Fair Value (Est) Discount (Est) Talenom Oyj (HLSE:TNOM) €3.52 €6.95 49.3% Selvita (WSE:SLV) PLN35.50 PLN69.87 49.2% Logic Instrument (ENXTPA:ALLOG) €2.18 €4.32 49.5% Laboratorios Farmaceuticos Rovi (BME:ROVI) €55.75 €109.12 48.9% JOST Werke (XTRA:JST) €52.10 €102.82 49.3% Echo Investment (WSE:ECH) PLN5.36 PLN10.70 49.9% doValue (BIT:DOV) €2.548 €5.00 49% cyan (XTRA:CYR) €2.20 €4.36 49.5% BHG Group (OM:BHG) SEK24.50 SEK48.78 49.8% Atea (OB:ATEA) NOK143.60 NOK282.50 49.2%

Click here to see the full list of 194 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Here's a peek at a few of the choices from the screener.

Sartorius Stedim Biotech

Overview: Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry globally, with a market cap of €17.47 billion.

Operations: The company's revenue is primarily derived from its Biopharm segment, which generated €2.90 billion.

Estimated Discount To Fair Value: 12.6%

Sartorius Stedim Biotech's recent earnings report shows strong cash flow with a net income increase to €68.5 million for Q2 2025, up from €47.6 million the previous year. The stock trades at approximately 12.6% below its estimated fair value of €205.46 and is expected to see significant earnings growth of 27.49% per year, outpacing the French market average. Despite high debt levels, strategic expansions and partnerships bolster its long-term prospects in biopharmaceutical manufacturing.

Upon reviewing our latest growth report, Sartorius Stedim Biotech's projected financial performance appears quite optimistic. Get an in-depth perspective on Sartorius Stedim Biotech's balance sheet by reading our health report here.ENXTPA:DIM Discounted Cash Flow as at Jul 2025

Landis+Gyr Group

Overview: Landis+Gyr Group AG, along with its subsidiaries, offers integrated energy management solutions to the utility sector across the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions and has a market cap of CHF1.99 billion.

Operations: The company's revenue is primarily derived from its operations in the Americas ($967.49 million), Europe, the Middle East, and Africa (EMEA) ($639.04 million), and the Asia Pacific region ($158.68 million).

Weiterlesen

Estimated Discount To Fair Value: 18.3%

Landis+Gyr Group's stock is trading at CHF69.2, approximately 18.3% below its estimated fair value of CHF84.73, suggesting potential undervaluation based on cash flows. The company's revenue is forecast to grow by 6.7% annually, surpassing the Swiss market average of 4%. Recent agreements with Withlacoochee River Electric Cooperative and advancements in smart grid technology may enhance future cash flows despite current profitability challenges and a recent net loss of US$150.46 million for fiscal year 2025.

Our comprehensive growth report raises the possibility that Landis+Gyr Group is poised for substantial financial growth. Click here and access our complete balance sheet health report to understand the dynamics of Landis+Gyr Group.SWX:LAND Discounted Cash Flow as at Jul 2025

Allegro.eu

Overview: Allegro.eu S.A. operates a leading commerce platform for consumers in Poland and internationally, with a market cap of PLN38.86 billion.

Operations: Allegro.eu generates revenue from its core commerce platform, serving consumers both in Poland and internationally.

Estimated Discount To Fair Value: 41.3%

Allegro.eu is trading at PLN36.89, significantly below its estimated fair value of PLN62.85, indicating it may be undervalued based on cash flows. The company reported Q1 2025 sales of PLN2.62 billion and net income of PLN296.5 million, showing growth from the previous year. Earnings are projected to grow at 20.65% annually, outpacing the Polish market's average growth rate while revenue is expected to increase by 10.2% per year.

The growth report we've compiled suggests that Allegro.eu's future prospects could be on the up. Click to explore a detailed breakdown of our findings in Allegro.eu's balance sheet health report.WSE:ALE Discounted Cash Flow as at Jul 2025

Summing It All Up

Reveal the 194 hidden gems among our Undervalued European Stocks Based On Cash Flows screener with a single click here. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Searching for a Fresh Perspective?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ENXTPA:DIM SWX:LAND and WSE:ALE.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

Kommentare anzeigen